What is NDC 72336-641?

72336-641 is the product NDC for Glimepiride 3 mg (glimepiride), Glimepiride 3 mg/1 tablet, listed with the FDA by Lifsa Drugs LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Glimepiride 3 mg (Glimepiride).

Lifsa Drugs LLC, NDC labeler code 72336. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Glimepiride 3 mg?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Glimepiride 3 mg NDC 72336-641 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)72336-641Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72336-0641Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72336-641-01	7233606410172336064101	100 TABLET in 1 BOTTLE (72336-641-01)Marketed from Aug 20, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Glimepiride 3 mg
Generic name (nonproprietary): glimepiride
Active ingredients: Glimepiride — 3 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Lifsa Drugs LLCNDC labeler code 72336
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091220
Marketing start: Aug 20, 2024
Listing expires: Dec 31, 2027
Other FDA classes: Sulfonylurea Compounds (Chemical structure)
Identifiers: Product ID 72336-641_8f56950f-d08d-44d4-9c7c-9830e9bfadb8SPL ID 8f56950f-d08d-44d4-9c7c-9830e9bfadb8SPL set ID 51157849-7990-4a8b-ae50-eda1baf93cfaRxCUI 153842UNII 6KY687524KUPC 0372336641012
Pharmacologic class: Sulfonylurea

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472336064101 followed by a unit qualifier and the quantity

Package 72336-0641-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 20, 2024.

Indications (excerpt from the label)

Glimepiride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see Clinical Studies (14.1) ] . Limitations of Use Glimepiride tablets should not be used for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis, as it would not be effective in these settings. Glimepiride is a sulfonylurea indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus ( 1 ). Limitations of Use: Not for treating type 1 diabetes mellitus or diabetic ketoacidosis ( 1 ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 72336-641

What is NDC 72336-641?: 72336-641 is the product NDC for Glimepiride 3 mg (glimepiride), Glimepiride 3 mg/1 tablet, listed with the FDA by Lifsa Drugs LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Glimepiride 3 mg (Glimepiride).
What is the active ingredient?: Glimepiride.
Who is the labeler?: Lifsa Drugs LLC, NDC labeler code 72336. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Glimepiride 3 mg?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under ANDA 091220

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 091220
Product	Strength	Form · route	Labeler	Product NDC
Glimepiride	Glimepiride 1 mg/1	TabletOral	NCS HealthCare of KY, Inc dba Vangard Labs	0615-8332
Glimepiride	Glimepiride 2 mg/1	TabletOral	NCS HealthCare of KY, Inc dba Vangard Labs	0615-8333
Glimepiride	Glimepiride 4 mg/1	TabletOral	NCS HealthCare of KY, Inc dba Vangard Labs	0615-8334
Glimepiride	Glimepiride 1 mg/1	TabletOral	Micro Labs Limited	42571-100
Glimepiride	Glimepiride 2 mg/1	TabletOral	Micro Labs Limited	42571-101
Glimepiride	Glimepiride 3 mg/1	TabletOral	Micro Labs Limited	42571-102
Glimepiride	Glimepiride 4 mg/1	TabletOral	Micro Labs Limited	42571-103
Glimepiride	Glimepiride 6 mg/1	TabletOral	Micro Labs Limited	42571-104
Glimepiride	Glimepiride 8 mg/1	TabletOral	Micro Labs Limited	42571-105
Glimepiride	Glimepiride 1 mg/1	TabletOral	BluePoint Laboratories	68001-584
Glimepiride	Glimepiride 2 mg/1	TabletOral	BluePoint Laboratories	68001-585
Glimepiride	Glimepiride 4 mg/1	TabletOral	BluePoint Laboratories	68001-586
Glimepiride	Glimepiride 1 mg/1	TabletOral	Bryant Ranch Prepack	71335-1885
Glimepiride	Glimepiride 2 mg/1	TabletOral	Bryant Ranch Prepack	71335-1886

Glimepiride 3 mg (Glimepiride) NDC 72336-641